The FDA announced that Teva Pharmaceuticals USA and Amerisource Health Services issued voluntary recalls for blood pressure ...
Sanjeev brings to Phathom a proven track record of building successful profitable pharmaceutical businesses of significant ...
TipRanks on MSN
Jubilant Pharmova Releases Financial Results for Q2 2025
Jubilant Pharmova Limited ( ($IN:JUBLPHARMA) ) has issued an announcement. Jubilant Pharmova Limited has announced the publication of its ...
The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...
Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market expectations, driven by unprecedented demand for its ...
But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...
Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.
Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
For its third quarter, AbbVie reaped just under $15.78 billion in revenue, which was 9% higher on a year-over-year basis.
The Ghana Pharmacists Advocacy Forum Friday condemned the assault perpetrated by a military officer against some civilians at a retail pharmacy outlet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results